ABBV — AbbVie Inc
In 2026 Q2, 18 of the 140 tracked hedge funds reported a position in AbbVie Inc (ABBV), worth $151.91M combined. Over the quarter 13 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Quadrature | $53.56M | 0.46% | NEW |
| VanEck | $49.26M | 0.03% | -24.5% |
| BOCHK | $10.47M | 1.70% | NEW |
| Navellier | $7.19M | 0.57% | +1% |
| ARS | $7.08M | 0.31% | -0.1% |
| Colrain | $6.30M | 2.10% | +0.4% |
| MWA | $4.57M | 2.10% | +1.4% |
| Chapin Davis | $3.97M | 0.70% | +10.5% |
| O'Neil | $3.45M | 0.77% | NEW |
| KRS | $2.16M | 1.00% | +2.6% |
| Parvin | $912.20K | 0.73% | NO CHANGE |
| Four Tree Island | $851.55K | 0.28% | NO CHANGE |
| Steadtrust | $611.94K | 0.31% | +0.3% |
| Cypress Point | $517.12K | 0.11% | +84.3% |
| Pingora | $429.05K | 0.25% | NO CHANGE |
| Schear | $309.83K | 0.10% | +13.2% |
| Polymer | $264.22K | 0.04% | NEW |
| Barnes Dennig | $755 | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.